Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4015 results

Sort By:

Effects of Nicotine Dependence on Multidimensional Health Outcomes

Study ID: NCT07474623
Start Date: 2026-04-15
End Date: 2027-07-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

212

Intervention / Treatment

Comprehensive Clinical Assessment

Sponsor

Izmir Democracy University

Source: clinicaltrials.gov

Share:
Add to list

Addressing Health Disparities in Normal Pressure Hydrocephalus (NPH) in Maryland

Study ID: NCT06426004
Start Date: 2026-04-01
End Date: 2030-03-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

660

Intervention / Treatment

patients will receive NPH education

primary care physicians (PCPs) will receive professional NPH education

A community health worker will assist PCP

Sponsor

Johns Hopkins Bloomberg School of Public Health

Source: clinicaltrials.gov

Share:
Add to list

Clinical Evaluation of Neorepair™ Acellular Matrix in Immediate Implant-Based Breast Reconstruction

Study ID: NCT07480421
Start Date: 2026-07-01
End Date: 2029-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Acellular matrix

Sponsor

Silimed Industria de Implantes Ltda

Source: clinicaltrials.gov

Share:
Add to list

A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Indian and Alaska Native Cancer Patients Living in Rural California

Study ID: NCT07332312
Start Date: 2026-06-30
End Date: 2028-11-13
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

71

Intervention / Treatment

Discussion

Discussion

Educational Intervention

Electronic Health Record Review

Interview

Interview

Patient Navigation

Survey Administration

Tailored Intervention

Sponsor

University of Southern California

Source: clinicaltrials.gov

Share:
Add to list

A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF) and Their Effects on Relapses in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS)

Study ID: NCT07483632
Start Date: 2026-11-16
End Date: 2035-06-19
Study Type

Interventional

Study Phase

Phase3

No. of Participants

185

Intervention / Treatment

Diroximel Fumarate

Dimethyl Fumarate

Fingolimod

Placebo matching DRF

Placebo matching DMF

Placebo matching fingolimod

Sponsor

Biogen

Source: clinicaltrials.gov

Share:
Add to list

GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHL

Study ID: NCT06875063
Start Date: 2026-04-30
End Date: 2027-05-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

45

Intervention / Treatment

GB5005 CART

Sponsor

The First Affiliated Hospital of Xiamen University

Source: clinicaltrials.gov

Share:
Add to list

Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer

Study ID: NCT07429487
Start Date: 2026-06-15
End Date: 2030-06-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

98

Intervention / Treatment

WHAT program

Sponsor

Antoine Lacassagne Center

Source: clinicaltrials.gov

Share:
Add to list

Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial

Study ID: NCT07148206
Start Date: 2026-05
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

40

Intervention / Treatment

Dronabinol Capsules

Epidiolex 100 mg/mL Oral Solution

Placebo Dronabinol

Placebo Epidiolex

Sponsor

Montefiore Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Bundled Cancer Screening and Genetic Services Navigation

Study ID: NCT07228000
Start Date: 2026-05-01
End Date: 2029-05-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

820

Intervention / Treatment

Breast cancer screening navigation

Multicancer screening navigation

Usual care genetics referral

Pretest education + usual care genetics referral

Sponsor

Georgetown University

Source: clinicaltrials.gov

Share:
Add to list

A Phase 2a Efficacy, Safety, Tolerability, and PK Study of SYT-510 in Participants With Generalized Anxiety Disorder

Study ID: NCT07478744
Start Date: 2026-04
End Date: 2027-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

24

Intervention / Treatment

SYT-510

Placebo

Sponsor

Synendos Therapeutics AG

Source: clinicaltrials.gov

Share:
Add to list